Agree. FNT is in a precarious position imo. It's not the only one trading below CR pricing. Difficult conditions in the spec sector. Markets are completely unforgiving atm.
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025